Opioids in cancer: The κ-opioid receptor (Review)

8Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The κ-opioid receptor (KOR) is one of the primary receptors of opioids and serves a vital role in the regulation of pain, anesthesia, addiction and other pathological and physiological processes. KOR is associated with several types of cancer and may influence cancer progression. It has been proposed that KOR may represent a new tumor molecular marker and provide a novel basis for molecular targeted therapies for cancer. However, the association between KOR and cancer remains to be explored comprehensively. The present review introduces KOR and its association with different types of cancer. Improved understanding of KOR may facilitate development of novel antitumor therapies.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhou, Q., Zhang, Z., Long, S., Li, W., Wang, B., & Liang, N. (2022, February 1). Opioids in cancer: The κ-opioid receptor (Review). Molecular Medicine Reports. Spandidos Publications. https://doi.org/10.3892/mmr.2021.12560

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free